A PYMNTS Company

FTC seeks public comment on Cardinal Health nuclear pharmacy sales to Patient Care Infusion

By  |  June 20, 2012
FTC seeks public comment on Cardinal Health nuclear pharmacy sales to Patient Care Infusion

The FTC is seeking public comment on Cardinal Health’s application to sell its former nuclear pharmacy assets to Patient Care Infusion. Cardinal is required to sell these assets–located in Las Vegas, Albuquerque, and El Paso–under the 2011 settlement with the FTC for its acquisition of three nuclear pharmacies from Biotech.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Public comments on the sale will be accepted until March 26, 2012.

    Source: FTC Press Release

     

    Related Content: Reviving Competition in Healthcare Markets: The Use of Section 5 of the FTC Act (David Balto)